A carregar...
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
The approval of targeted therapies for metastatic colorectal cancer (mCRC) has led to important improvements in patient outcomes. However, it is still necessary to increase individualisation of treatments based on tumour genetic profiles to optimise efficacy, while minimising toxicity. As such, ther...
Na minha lista:
| Publicado no: | Drugs |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728290/ https://ncbi.nlm.nih.gov/pubmed/31347092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01165-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|